1. The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
   Hirotetsu Takagi et al, 2021, Cells CrossRef
2. The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures
   Hai-Feng Zhang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
3. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma
   Heng Jiang et al, 2023, Journal of Clinical Medicine CrossRef
4. Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
   Hongyu Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
5. The altered lipidome of hepatocellular carcinoma
   Shawn Lu Wen Tan et al, 2022, Seminars in Cancer Biology CrossRef
6. The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
   Tanner Wright et al, 2021, Epigenomes CrossRef
7. Role of angiotensin in different malignancies
   Manoj Kumar Kashyap et al, 2023, Angiotensin CrossRef
8. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma
   Cheng Yan et al, 2022, Journal of Translational Medicine CrossRef
9. Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
   Hiroyuki Nojima et al, 2024, Cancers CrossRef